Matthew Gline serves as Executive at Roivant Sciences Ltd., where they oversee executive responsibilities. Since joining the company, Matthew Gline has executed 62 insider transactions totaling $63.4M, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 15, 2025 involved transacting 1,329,325 shares valued at $28.8M.
Matthew Gline currently holds 17,287,081 shares of Roivant Sciences Ltd. (ROIV), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Matthew Gline has been a net seller of ROIV stock. They have purchased $50.0K and sold $63.3M worth of shares.
Matthew Gline's most recent insider trade was on Dec 15, 2025, when they sold 1,329,325 shares at $21.68 per share.
Get notified when new Form 4 filings are submitted
| $21.68 |
| Discretionary |
| Dec 15, 2025 | ROIV | $12.3M | Sale | 566,116 | $21.68 | Discretionary |
| Dec 15, 2025 | ROIV | $17.3M | Option Exercise | 1,363,711 | $12.68 | Discretionary |
| Dec 15, 2025 | ROIV | $5.0M | Sale | 230,357 | $21.68 | Discretionary |
| Dec 15, 2025 | ROIV | $950.4K | Option Exercise | 234,096 | $4.06 | Discretionary |
| Dec 15, 2025 | ROIV | $28.8M | Option Exercise | 2,272,852 | $12.68 | Discretionary |
| Dec 15, 2025 | ROIV | $81.1K | Other | 3,739 | $21.68 | Discretionary |
| Dec 15, 2025 | ROIV | $20.5M | Sale | 943,527 | $21.68 | Discretionary |
| Sep 18, 2025 | ROIV | $50.0K | Purchase | 3,315 | $15.07 | Discretionary |
| Sep 23, 2024 | ROIV | $6.0M | Option Exercise | 1,550,000 | $3.85 | Planned |
| Sep 23, 2024 | ROIV | $23.4M | Sale | 1,983,257 | $11.79 | Planned |
| Sep 23, 2024 | ROIV | $6.0M | Other | 498,539 | $11.97 | Planned |
| Sep 20, 2024 | ROIV | $131.0K | Payment | 10,945 | $11.97 | Planned |
| Aug 20, 2024 | ROIV | $125.7K | Payment | 10,947 | $11.48 | Planned |
| Jul 26, 2024 | ROIV | $0 | Award | 2,754,821 | $N/A | Discretionary |
| Jul 26, 2024 | ROIV | $0 | Award | 14,450,000 | $N/A | Discretionary |
| Jul 20, 2024 | ROIV | $120.4K | Payment | 10,945 | $11.00 | Planned |
| Jun 20, 2024 | ROIV | $118.2K | Payment | 10,945 | $10.80 | Planned |
| May 20, 2024 | ROIV | $124.4K | Payment | 10,945 | $11.37 | Planned |
| Apr 20, 2024 | ROIV | $114.5K | Payment | 10,945 | $10.46 | Planned |
| Mar 30, 2024 | ROIV | $2.3M | Payment | 215,991 | $10.54 | Planned |
| Mar 30, 2024 | ROIV | $0 | Option Exercise | 390,579 | $N/A | Planned |
| Mar 20, 2024 | ROIV | $109.6K | Payment | 10,945 | $10.01 | Planned |
| Feb 20, 2024 | ROIV | $126.3K | Payment | 10,945 | $11.54 | Planned |
| Jan 20, 2024 | ROIV | $113.3K | Payment | 10,945 | $10.35 | Planned |
| Dec 27, 2023 | ROIV | $255.3K | Payment | 22,043 | $11.58 | Planned |
| Dec 27, 2023 | ROIV | $0 | Option Exercise | 38,453 | $N/A | Planned |
| Dec 20, 2023 | ROIV | $109.0K | Payment | 10,945 | $9.96 | Planned |
| Nov 22, 2023 | ROIV | $98.2K | Other | 11,318 | $8.68 | Planned |